BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12030716)

  • 1. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
    Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
    Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics.
    Walmrath D; Grimminger F; Pappert D; Knothe C; Obertacke U; Benzing A; Günther A; Schmehl T; Leuchte H; Seeger W
    Eur Respir J; 2002 May; 19(5):805-10. PubMed ID: 12030717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration.
    Günther A; Balser M; Schmidt R; Markart P; Olk A; Börgermann J; Splittgerber FH; Seeger W; Friedrich I
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):344-54. PubMed ID: 14762341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
    Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
    Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.
    Schmidt R; Markart P; Ruppert C; Wygrecka M; Kuchenbuch T; Walmrath D; Seeger W; Guenther A
    Respir Res; 2007 Jul; 8(1):55. PubMed ID: 17662121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
    Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.
    Walmrath D; Günther A; Ghofrani HA; Schermuly R; Schneider T; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1996 Jul; 154(1):57-62. PubMed ID: 8680699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
    Gregory TJ; Longmore WJ; Moxley MA; Whitsett JA; Reed CR; Fowler AA; Hudson LD; Maunder RJ; Crim C; Hyers TM
    J Clin Invest; 1991 Dec; 88(6):1976-81. PubMed ID: 1752956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
    Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs.
    Friedrich I; Börgermann J; Splittgerber FH; Brinkmann M; Reidemeister JC; Silber RE; Seeger W; Schmidt R; Günther A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):335-43. PubMed ID: 14762340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.
    Huang TK; Uyehara CF; Balaraman V; Miyasato CY; Person D; Egan E; Easa D
    Lung; 2004; 182(1):15-25. PubMed ID: 14752669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).
    Gommers D; Eijking EP; So KL; van't Veen A; Lachmann B
    Intensive Care Med; 1998 May; 24(5):494-500. PubMed ID: 9660267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
    Friedrich B; Schmidt R; Reiss I; Günther A; Seeger W; Müller M; Thul J; Schranz D; Gortner L
    Crit Care Med; 2003 Jan; 31(1):284-90. PubMed ID: 12545030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant alteration and replacement in acute respiratory distress syndrome.
    Günther A; Ruppert C; Schmidt R; Markart P; Grimminger F; Walmrath D; Seeger W
    Respir Res; 2001; 2(6):353-64. PubMed ID: 11737935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.